Jean M Lawrence1,2, Jasmin Divers3, Scott Isom4, Sharon Saydah5, Giuseppina Imperatore6, Catherine Pihoker7, Santica M Marcovina8, Elizabeth J Mayer-Davis9, Richard F Hamman10, Lawrence Dolan11, Dana Dabelea10,12,13, David J Pettitt14, Angela D Liese15. 1. Division of Epidemiologic Research, Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena. 2. Division of Diabetes, Endocrinology and Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland. 3. Division of Health Services Research, Department of Foundations of Medicine, New York University Langone School of Medicine, Mineola. 4. Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, North Carolina. 5. Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Hyattsville, Maryland. 6. Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia. 7. Department of Pediatrics, University of Washington, Seattle. 8. Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington, Seattle. 9. Departments of Nutrition and Medicine, University of North Carolina at Chapel Hill. 10. Department of Epidemiology, Colorado School of Public Health, Anschutz Medical Campus, Aurora. 11. Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. 12. Lifecourse Epidemiology of Adiposity and Diabetes (LEAD) Center, University of Colorado, Aurora. 13. Department of Pediatrics, University of Colorado School of Medicine, Aurora. 14. Santa Barbara, California. 15. Department of Epidemiology and Biostatistics, University of South Carolina Arnold School of Public Health, Columbia.
Abstract
Importance: Changes in the prevalence of youth-onset diabetes have previously been observed. Objective: To estimate changes in prevalence of type 1 and type 2 diabetes in youths in the US from 2001 to 2017. Design, Setting, and Participants: In this cross-sectional observational study, individuals younger than 20 years with physician-diagnosed diabetes were enumerated from 6 areas in the US (4 geographic areas, 1 health plan, and select American Indian reservations) for 2001, 2009, and 2017. Exposures: Calendar year. Main Outcomes and Measures: Estimated prevalence of physician-diagnosed type 1 and type 2 diabetes overall and by race and ethnicity, age, and sex. Results: Among youths 19 years or younger, 4958 of 3.35 million had type 1 diabetes in 2001, 6672 of 3.46 million had type 1 diabetes in 2009, and 7759 of 3.61 million had type 1 diabetes in 2017; among those aged 10 to 19 years, 588 of 1.73 million had type 2 diabetes in 2001, 814 of 1.85 million had type 2 diabetes in 2009, and 1230 of 1.85 million had type 2 diabetes in 2017. The estimated type 1 diabetes prevalence per 1000 youths for those 19 years or younger increased significantly from 1.48 (95% CI, 1.44-1.52) in 2001 to 1.93 (95% CI, 1.88-1.98) in 2009 to 2.15 (95% CI, 2.10-2.20) in 2017, an absolute increase of 0.67 per 1000 youths (95%, CI, 0.64-0.70) and a 45.1% (95% CI, 40.0%-50.4%) relative increase over 16 years. The greatest absolute increases were observed among non-Hispanic White (0.93 per 1000 youths [95% CI, 0.88-0.98]) and non-Hispanic Black (0.89 per 1000 youths [95% CI, 0.88-0.98]) youths. The estimated type 2 diabetes prevalence per 1000 youths aged 10 to 19 years increased significantly from 0.34 (95% CI, 0.31-0.37) in 2001 to 0.46 (95% CI, 0.43-0.49) in 2009 to 0.67 (95% CI, 0.63-0.70) in 2017, an absolute increase of 0.32 per 1000 youths (95% CI, 0.30-0.35) and a 95.3% (95% CI, 77.0%-115.4%) relative increase over 16 years. The greatest absolute increases were observed among non-Hispanic Black (0.85 per 1000 youths [95% CI, 0.74-0.97]) and Hispanic (0.57 per 1000 youths [95% CI, 0.51-0.64]) youths. Conclusions and Relevance: In 6 areas of the US from 2001 to 2017, the estimated prevalence of diabetes among children and adolescents increased for both type 1 and type 2 diabetes.
Importance: Changes in the prevalence of youth-onset diabetes have previously been observed. Objective: To estimate changes in prevalence of type 1 and type 2 diabetes in youths in the US from 2001 to 2017. Design, Setting, and Participants: In this cross-sectional observational study, individuals younger than 20 years with physician-diagnosed diabetes were enumerated from 6 areas in the US (4 geographic areas, 1 health plan, and select American Indian reservations) for 2001, 2009, and 2017. Exposures: Calendar year. Main Outcomes and Measures: Estimated prevalence of physician-diagnosed type 1 and type 2 diabetes overall and by race and ethnicity, age, and sex. Results: Among youths 19 years or younger, 4958 of 3.35 million had type 1 diabetes in 2001, 6672 of 3.46 million had type 1 diabetes in 2009, and 7759 of 3.61 million had type 1 diabetes in 2017; among those aged 10 to 19 years, 588 of 1.73 million had type 2 diabetes in 2001, 814 of 1.85 million had type 2 diabetes in 2009, and 1230 of 1.85 million had type 2 diabetes in 2017. The estimated type 1 diabetes prevalence per 1000 youths for those 19 years or younger increased significantly from 1.48 (95% CI, 1.44-1.52) in 2001 to 1.93 (95% CI, 1.88-1.98) in 2009 to 2.15 (95% CI, 2.10-2.20) in 2017, an absolute increase of 0.67 per 1000 youths (95%, CI, 0.64-0.70) and a 45.1% (95% CI, 40.0%-50.4%) relative increase over 16 years. The greatest absolute increases were observed among non-Hispanic White (0.93 per 1000 youths [95% CI, 0.88-0.98]) and non-Hispanic Black (0.89 per 1000 youths [95% CI, 0.88-0.98]) youths. The estimated type 2 diabetes prevalence per 1000 youths aged 10 to 19 years increased significantly from 0.34 (95% CI, 0.31-0.37) in 2001 to 0.46 (95% CI, 0.43-0.49) in 2009 to 0.67 (95% CI, 0.63-0.70) in 2017, an absolute increase of 0.32 per 1000 youths (95% CI, 0.30-0.35) and a 95.3% (95% CI, 77.0%-115.4%) relative increase over 16 years. The greatest absolute increases were observed among non-Hispanic Black (0.85 per 1000 youths [95% CI, 0.74-0.97]) and Hispanic (0.57 per 1000 youths [95% CI, 0.51-0.64]) youths. Conclusions and Relevance: In 6 areas of the US from 2001 to 2017, the estimated prevalence of diabetes among children and adolescents increased for both type 1 and type 2 diabetes.
Authors: Molly M Lamb; Melissa Miller; Jennifer A Seifert; Brittni Frederiksen; Miranda Kroehl; Marian Rewers; Jill M Norris Journal: Pediatr Diabetes Date: 2014-01-20 Impact factor: 4.866
Authors: Cynthia L Ogden; Cheryl D Fryar; Crescent B Martin; David S Freedman; Margaret D Carroll; Qiuping Gu; Craig M Hales Journal: JAMA Date: 2020-09-22 Impact factor: 56.272
Authors: Soulmaz Fazeli Farsani; Patrick C Souverein; Marja M J van der Vorst; Catherijne A J Knibbe; Ron M C Herings; Anthonius de Boer; Aukje K Mantel-Teeuwisse Journal: Pediatr Diabetes Date: 2014-11-07 Impact factor: 4.866
Authors: Dana Dabelea; Catherine Pihoker; Jennifer W Talton; Ralph B D'Agostino; Wilfred Fujimoto; Georgeanna J Klingensmith; Jean M Lawrence; Barbara Linder; Santica M Marcovina; Elizabeth J Mayer-Davis; Giuseppina Imperatore; Lawrence M Dolan Journal: Diabetes Care Date: 2011-06-02 Impact factor: 19.112
Authors: Tessa L Crume; Richard F Hamman; Scott Isom; Jasmin Divers; Elizabeth J Mayer-Davis; Angela D Liese; Sharon Saydah; Jean M Lawrence; Catherine Pihoker; Dana Dabelea Journal: Pediatr Diabetes Date: 2020-10-06 Impact factor: 3.409
Authors: Nicholas P Deputy; Shin Y Kim; Elizabeth J Conrey; Kai McKeever Bullard Journal: MMWR Morb Mortal Wkly Rep Date: 2018-11-02 Impact factor: 17.586
Authors: Jasmin Divers; Elizabeth J Mayer-Davis; Jean M Lawrence; Scott Isom; Dana Dabelea; Lawrence Dolan; Giuseppina Imperatore; Santica Marcovina; David J Pettitt; Catherine Pihoker; Richard F Hamman; Sharon Saydah; Lynne E Wagenknecht Journal: MMWR Morb Mortal Wkly Rep Date: 2020-02-14 Impact factor: 35.301
Authors: Reza Mohebi; Chen Chen; Nasrien E Ibrahim; Cian P McCarthy; Hanna K Gaggin; Daniel E Singer; Emily P Hyle; Jason H Wasfy; James L Januzzi Journal: J Am Coll Cardiol Date: 2022-08-09 Impact factor: 27.203
Authors: Katherine R Tuttle; Leslie Wong; Wendy St Peter; Glenda Roberts; Janani Rangaswami; Amy Mottl; Alan S Kliger; Raymond C Harris; Patrick O Gee; Kevin Fowler; David Cherney; Frank C Brosius; Christos Argyropoulos; Susan E Quaggin Journal: Clin J Am Soc Nephrol Date: 2022-06-01 Impact factor: 10.614
Authors: Mary O Whipple; Ana J Pinto; Layla A Abushamat; Audrey Bergouignan; Kristina Chapman; Amy G Huebschmann; Kevin S Masters; Kristen J Nadeau; Rebecca L Scalzo; Irene E Schauer; Deirdre Rafferty; Jane E B Reusch; Judith G Regensteiner Journal: Diabetes Care Date: 2022-09-01 Impact factor: 17.152
Authors: Jean M Lawrence; Kristi Reynolds; Sharon H Saydah; Amy Mottl; Catherine Pihoker; Dana Dabelea; Lawrence Dolan; Leora Henkin; Angela D Liese; Scott Isom; Jasmin Divers; Lynne Wagenknecht Journal: Diabetes Care Date: 2021-10-04 Impact factor: 19.112
Authors: Mary Ellen Vajravelu; Talia Alyssa Hitt; NaDea Mak; Aliya Edwards; Jonathan Mitchell; Lisa Schwartz; Andrea Kelly; Sandra Amaral Journal: JMIR Diabetes Date: 2022-04-06